What We're Reading: Page 248
Industry reads hand-picked by our editors
Oct 30, 2018
Oct 29, 2018
-
The New York Times
Why Private Equity Is Furious Over a Paper in a Dermatology Journal
-
Axios
Trump's plan to bring down U.S. drug prices misses root causes
-
STAT
How an outsider bucked prevailing Alzheimer's theory, clawed for validation
-
MedTech Dive
5 sticking points in EU medical device reg transition
Oct 26, 2018
Oct 25, 2018
Oct 24, 2018
-
Axios
Express Scripts to open up mail-order pharmacy network
-
Harvard Business Review
How Lilly Is Getting More Women into Leadership Positions
-
Financial Times
Fast-track flu vaccine raises hopes for quicker drugs approvals
Oct 23, 2018
-
The Wall Street Journal
The Illegal Ingredients in Your Dietary Supplements - WSJ
-
BioCentury
FDA advisory committee to consider CV studies for diabetes drugs
-
STAT
Mallinckrodt will be honored for research into a drug that causes sticker shock
-
Reuters
Johnson & Johnson makes $2.1 billion offer to buy out Japan cosmetics firm Ci:z
Oct 22, 2018
-
The Wall Street Journal
A Billionaire Pledges to Fight High Drug Prices, and the Industry Is Rattled
-
The New York TImes
What Big Pharma Fears Most: A Trump Alliance With Democrats to Cut Drug Prices
-
Reuters
Merck KGaA says might strike partnership deal this year
-
STAT
Saving Mila: How doctors raced to stop a young girl's rare disease
Previous
